In conclusion, our work provides a mechanistic explanation for a group of human genetic diseases affecting CMG activation and also establishes dysfunctional replication origin activation as a prominent mechanism inducing genome instability upon loss of the TRP53 and CDKN1A/P21 tumor suppressors. The gene discussed is TP53; the disease is hereditary disease.